Novo Nordisk A/S
Long

NVO hit downside price target

123
NVO just hit the downside price target with this recent market pullback, this momentum trend has been in effect since Nov 2022. I expect this to pick back up with a possible wick slightly lower than here. I think we see a retest to 142$ in the coming weeks. I am debating adding LEAPs on this bad boy but I think the company is overvalued, I do not fade these cult movers though.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.